BioCentury
ARTICLE | Clinical News

Nouriast istradefylline regulatory update

April 1, 2013 7:00 AM UTC

Japan approved an NDA from Kyowa for Nouriast istradefylline to improve the "wearing-off" phenomena in Parkinson's disease (PD) patients receiving levodopa-containing therapy. Kyowa said it plans to l...